1075249-37-4 Usage
Uses
Used in Pharmaceutical Development:
Boc-6-Amino-5-methylpyridine-3-boronic acid pinacol ester is used as a key intermediate in the synthesis of pharmaceuticals for its ability to form stable complexes with biological targets, contributing to the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Synthesis:
In the agrochemical industry, Boc-6-Amino-5-methylpyridine-3-boronic acid pinacol ester is utilized as a building block for the creation of agrochemicals, such as pesticides and herbicides, due to its reactivity and potential to form complexes with biologically relevant targets in plants and pests.
Used in Organic Synthesis:
Boc-6-Amino-5-methylpyridine-3-boronic acid pinacol ester is employed as a versatile reagent in organic synthesis for the construction of complex organic molecules. Its boronic acid functionality allows for Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds and the synthesis of a wide range of organic compounds.
Used in Research and Development:
In academic and industrial research settings, Boc-6-Amino-5-methylpyridine-3-boronic acid pinacol ester is used as a valuable tool for exploring new chemical reactions and developing innovative synthetic methods. Its unique properties and reactivity make it an important compound for advancing the frontiers of chemical science.
Check Digit Verification of cas no
The CAS Registry Mumber 1075249-37-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,2,4 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1075249-37:
(9*1)+(8*0)+(7*7)+(6*5)+(5*2)+(4*4)+(3*9)+(2*3)+(1*7)=154
154 % 10 = 4
So 1075249-37-4 is a valid CAS Registry Number.
1075249-37-4Relevant academic research and scientific papers
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
-
Page/Page column 31-32, (2008/12/08)
The invention provides compounds and pharmaceutical compositions, and methods for using such compounds to treat, ameliorate or prevent a condition associated with activity of cannabinoid receptor 1 (CB1).
